Treatment of allergic eosinophilic asthma through engineered IL-5-anchored chimeric antigen receptor T cells.
Chen S, Chen G, Xu F, Sun B, Chen X, Hu W, Li F, Syeda MZ, Chen H, Wu Y, Wu P, Jing R, Geng X, Zhang L, Tang L, Li W, Chen Z, Zhang C, Sun J, Chen W, Shen H, Ying S.
Chen S, et al. Among authors: chen z, chen g, chen w, chen x, chen h.
Cell Discov. 2022 Aug 16;8(1):80. doi: 10.1038/s41421-022-00433-y.
Cell Discov. 2022.
PMID: 35973984
Free PMC article.